JP2015510868A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015510868A5 JP2015510868A5 JP2014559833A JP2014559833A JP2015510868A5 JP 2015510868 A5 JP2015510868 A5 JP 2015510868A5 JP 2014559833 A JP2014559833 A JP 2014559833A JP 2014559833 A JP2014559833 A JP 2014559833A JP 2015510868 A5 JP2015510868 A5 JP 2015510868A5
- Authority
- JP
- Japan
- Prior art keywords
- trifluoromethyl
- benzyl
- amino
- piperidine
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 cyano, nitro, amino Chemical group 0.000 claims 84
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims 52
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 25
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 25
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 22
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 21
- 125000003118 aryl group Chemical group 0.000 claims 20
- 125000006653 (C1-C20) heteroaryl group Chemical group 0.000 claims 18
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 18
- 125000000623 heterocyclic group Chemical group 0.000 claims 17
- 229910052739 hydrogen Inorganic materials 0.000 claims 17
- 239000001257 hydrogen Substances 0.000 claims 17
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 13
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 9
- 125000003282 alkyl amino group Chemical group 0.000 claims 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 8
- 125000004414 alkyl thio group Chemical group 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 229910052736 halogen Inorganic materials 0.000 claims 6
- 150000002367 halogens Chemical group 0.000 claims 6
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 4
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 4
- 125000006508 2,6-difluorobenzyl group Chemical group [H]C1=C([H])C(F)=C(C(F)=C1[H])C([H])([H])* 0.000 claims 3
- 125000002252 acyl group Chemical group 0.000 claims 3
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000000651 prodrug Substances 0.000 claims 3
- 229940002612 prodrug Drugs 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 3
- 229920002554 vinyl polymer Polymers 0.000 claims 3
- 208000007913 Pituitary Neoplasms Diseases 0.000 claims 2
- 206010046798 Uterine leiomyoma Diseases 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 239000003163 gonadal steroid hormone Substances 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 201000010260 leiomyoma Diseases 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 238000011321 prophylaxis Methods 0.000 claims 2
- 235000019260 propionic acid Nutrition 0.000 claims 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 2
- 238000011282 treatment Methods 0.000 claims 2
- 125000006573 (C1-C10) heteroaryl group Chemical group 0.000 claims 1
- VTRIFTLAGXOFRH-QFIPXVFZSA-N 1'-acetyl-3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C1CN(C(=O)C)CCC21C(C(=O)N(C[C@H](N)C=1C=CC=CC=1)C(=O)N1CC=3C(=CC=CC=3F)C(F)(F)F)=C1CO2 VTRIFTLAGXOFRH-QFIPXVFZSA-N 0.000 claims 1
- CDSFMIKQRZWZQK-NDEPHWFRSA-N 2-[[3-[(2R)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-2,4-dioxospiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-1'-yl]methyl]-6-fluorobenzonitrile Chemical compound N[C@@H](CN1C(N(C2=C(C1=O)C1(OC2)CCN(CC1)CC1=C(C#N)C(=CC=C1)F)CC1=C(C=CC=C1C(F)(F)F)F)=O)C1=CC=CC=C1 CDSFMIKQRZWZQK-NDEPHWFRSA-N 0.000 claims 1
- OGCCIDQQRPSRBO-NDEPHWFRSA-N 2-[[3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-2,4-dioxospiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-1'-yl]methyl]benzonitrile Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC=C1C#N OGCCIDQQRPSRBO-NDEPHWFRSA-N 0.000 claims 1
- IZOQAACJVHPALY-NDEPHWFRSA-N 3-[(2R)-2-amino-2-phenylethyl]-1'-(1-benzothiophen-7-ylmethyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound N[C@@H](CN1C(N(C2=C(C1=O)C1(OC2)CCN(CC1)CC1=CC=CC2=C1SC=C2)CC2=C(C=CC=C2C(F)(F)F)F)=O)C2=CC=CC=C2 IZOQAACJVHPALY-NDEPHWFRSA-N 0.000 claims 1
- YUSCJUDVHMJTRP-DEOSSOPVSA-N 3-[(2R)-2-amino-2-phenylethyl]-1'-(2,2-dimethylpropyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound CC(C)(C)CN1CCC2(CC1)OCc1c2c(=O)n(C[C@H](N)c2ccccc2)c(=O)n1Cc1c(F)cccc1C(F)(F)F YUSCJUDVHMJTRP-DEOSSOPVSA-N 0.000 claims 1
- VGKVUIZJSJJBQC-VWLOTQADSA-N 3-[(2R)-2-amino-2-phenylethyl]-1'-[(2-chloropyridin-3-yl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound N[C@@H](CN1C(N(C2=C(C1=O)C1(OC2)CCN(CC1)CC=1C(=NC=CC1)Cl)CC1=C(C=CC=C1C(F)(F)F)F)=O)C1=CC=CC=C1 VGKVUIZJSJJBQC-VWLOTQADSA-N 0.000 claims 1
- OSMNMVLWNHVRNA-MHZLTWQESA-N 3-[(2R)-2-amino-2-phenylethyl]-1'-[(3-chlorophenyl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound N[C@@H](CN1C(N(C2=C(C1=O)C1(OC2)CCN(CC1)CC1=CC(=CC=C1)Cl)CC1=C(C=CC=C1C(F)(F)F)F)=O)C1=CC=CC=C1 OSMNMVLWNHVRNA-MHZLTWQESA-N 0.000 claims 1
- MXSOOPALMZZQNG-QHCPKHFHSA-N 3-[(2R)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-(2-methylpropanoyl)spiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound CC(C)C(=O)N1CCC2(CC1)OCc1c2c(=O)n(C[C@H](N)c2ccccc2)c(=O)n1Cc1c(F)cccc1C(F)(F)F MXSOOPALMZZQNG-QHCPKHFHSA-N 0.000 claims 1
- GVTCTYIOHNARND-SANMLTNESA-N 3-[(2R)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-(2-morpholin-4-ylethyl)spiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound N[C@@H](CN1C(N(C2=C(C1=O)C1(OC2)CCN(CC1)CCN1CCOCC1)CC1=C(C=CC=C1C(F)(F)F)F)=O)C1=CC=CC=C1 GVTCTYIOHNARND-SANMLTNESA-N 0.000 claims 1
- LIMGOFOGIIJPTC-MHZLTWQESA-N 3-[(2R)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[(3-hydroxyphenyl)methyl]spiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound N[C@@H](CN1C(N(C2=C(C1=O)C1(OC2)CCN(CC1)CC1=CC(=CC=C1)O)CC1=C(C=CC=C1C(F)(F)F)F)=O)C1=CC=CC=C1 LIMGOFOGIIJPTC-MHZLTWQESA-N 0.000 claims 1
- MPZYOJKQSHWECV-NDEPHWFRSA-N 3-[(2R)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[(3-methoxyphenyl)methyl]spiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound COc1cccc(CN2CCC3(CC2)OCc2c3c(=O)n(C[C@H](N)c3ccccc3)c(=O)n2Cc2c(F)cccc2C(F)(F)F)c1 MPZYOJKQSHWECV-NDEPHWFRSA-N 0.000 claims 1
- PNRRJKMEMKYSDB-NDEPHWFRSA-N 3-[(2R)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[(3-methylsulfanylphenyl)methyl]spiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound N[C@@H](CN1C(N(C2=C(C1=O)C1(OC2)CCN(CC1)CC1=CC(=CC=C1)SC)CC1=C(C=CC=C1C(F)(F)F)F)=O)C1=CC=CC=C1 PNRRJKMEMKYSDB-NDEPHWFRSA-N 0.000 claims 1
- MMVBZKXGUCCNIL-NDEPHWFRSA-N 3-[(2R)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[(4-methoxyphenyl)methyl]spiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound COc1ccc(CN2CCC3(CC2)OCc2c3c(=O)n(C[C@H](N)c3ccccc3)c(=O)n2Cc2c(F)cccc2C(F)(F)F)cc1 MMVBZKXGUCCNIL-NDEPHWFRSA-N 0.000 claims 1
- HHKLWBNWCWSOPN-MHZLTWQESA-N 3-[(2R)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[(5-methylpyridin-3-yl)methyl]spiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound Cc1cncc(CN2CCC3(CC2)OCc2c3c(=O)n(C[C@H](N)c3ccccc3)c(=O)n2Cc2c(F)cccc2C(F)(F)F)c1 HHKLWBNWCWSOPN-MHZLTWQESA-N 0.000 claims 1
- NOQKRZONRQFIDH-NDEPHWFRSA-N 3-[(2R)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[[3-(trifluoromethyl)phenyl]methyl]spiro[6,7-dihydrocyclopenta[d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound N[C@@H](Cn1c(=O)c2c(CCC22CCN(Cc3cccc(c3)C(F)(F)F)CC2)n(Cc2c(F)cccc2C(F)(F)F)c1=O)c1ccccc1 NOQKRZONRQFIDH-NDEPHWFRSA-N 0.000 claims 1
- BKQSONWVITWCBF-NRFANRHFSA-N 3-[(2R)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-methylspiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound CN1CCC2(CC1)OCc1c2c(=O)n(C[C@H](N)c2ccccc2)c(=O)n1Cc1c(F)cccc1C(F)(F)F BKQSONWVITWCBF-NRFANRHFSA-N 0.000 claims 1
- JZRQJSWGNZGQJA-SANMLTNESA-N 3-[(2r)-2-amino-2-phenylethyl]-1'-[(2,3-difluorophenyl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC(F)=C1F JZRQJSWGNZGQJA-SANMLTNESA-N 0.000 claims 1
- NWNHBLQVDGFZGD-MHZLTWQESA-N 3-[(2r)-2-amino-2-phenylethyl]-1'-[(2-chlorophenyl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC=C1Cl NWNHBLQVDGFZGD-MHZLTWQESA-N 0.000 claims 1
- LLZYIIBYXSSRAJ-SANMLTNESA-N 3-[(2r)-2-amino-2-phenylethyl]-1'-[(2-fluoro-3-methoxyphenyl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound COC1=CC=CC(CN2CCC3(CC2)C2=C(N(C(=O)N(C[C@H](N)C=4C=CC=CC=4)C2=O)CC=2C(=CC=CC=2F)C(F)(F)F)CO3)=C1F LLZYIIBYXSSRAJ-SANMLTNESA-N 0.000 claims 1
- CXWFHGSQTPQUGG-MHZLTWQESA-N 3-[(2r)-2-amino-2-phenylethyl]-1'-[(2-fluorophenyl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC=C1F CXWFHGSQTPQUGG-MHZLTWQESA-N 0.000 claims 1
- RJBYXCDAMSXWIE-MHZLTWQESA-N 3-[(2r)-2-amino-2-phenylethyl]-1'-[(3-chlorophenyl)methyl]-1-[(2,6-difluorophenyl)methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC(Cl)=C1 RJBYXCDAMSXWIE-MHZLTWQESA-N 0.000 claims 1
- HWZJKDYRSZGMOV-NDEPHWFRSA-N 3-[(2r)-2-amino-2-phenylethyl]-1'-[(3-chlorophenyl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[6,7-dihydrocyclopenta[d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1CCC2(CC1)CCN1CC1=CC=CC(Cl)=C1 HWZJKDYRSZGMOV-NDEPHWFRSA-N 0.000 claims 1
- AXEOVYRLDBREGX-MHZLTWQESA-N 3-[(2r)-2-amino-2-phenylethyl]-1'-[(3-fluorophenyl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC(F)=C1 AXEOVYRLDBREGX-MHZLTWQESA-N 0.000 claims 1
- MNANXXJRDZDWPG-MHZLTWQESA-N 3-[(2r)-2-amino-2-phenylethyl]-1'-[(4-chlorophenyl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=C(Cl)C=C1 MNANXXJRDZDWPG-MHZLTWQESA-N 0.000 claims 1
- GVAJYXKTBHSEOO-MHZLTWQESA-N 3-[(2r)-2-amino-2-phenylethyl]-1'-[(4-fluorophenyl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=C(F)C=C1 GVAJYXKTBHSEOO-MHZLTWQESA-N 0.000 claims 1
- INPNCSMBGOGVML-VWLOTQADSA-N 3-[(2r)-2-amino-2-phenylethyl]-1'-[(5-chlorofuran-2-yl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[6,7-dihydrocyclopenta[d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1CCC2(CC1)CCN1CC1=CC=C(Cl)O1 INPNCSMBGOGVML-VWLOTQADSA-N 0.000 claims 1
- FGHIRSMYKDHMIF-DEOSSOPVSA-N 3-[(2r)-2-amino-2-phenylethyl]-1'-[(5-chlorofuran-2-yl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=C(Cl)O1 FGHIRSMYKDHMIF-DEOSSOPVSA-N 0.000 claims 1
- JTGUNEYXDVYRLY-VWLOTQADSA-N 3-[(2r)-2-amino-2-phenylethyl]-1'-[(6-chloropyridin-3-yl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=C(Cl)N=C1 JTGUNEYXDVYRLY-VWLOTQADSA-N 0.000 claims 1
- IRSPQGZZBIDNHL-NDEPHWFRSA-N 3-[(2r)-2-amino-2-phenylethyl]-1'-benzyl-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[6,7-dihydrocyclopenta[d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1CCC2(CC1)CCN1CC1=CC=CC=C1 IRSPQGZZBIDNHL-NDEPHWFRSA-N 0.000 claims 1
- COLADWQPOMUBEY-DEOSSOPVSA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[(2,6-difluorophenyl)methyl]-1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=C(C(F)(F)F)O1 COLADWQPOMUBEY-DEOSSOPVSA-N 0.000 claims 1
- AHFCDOSOHIGNJG-DEOSSOPVSA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-(1,2-oxazol-3-ylmethyl)spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC=1C=CON=1 AHFCDOSOHIGNJG-DEOSSOPVSA-N 0.000 claims 1
- GLTBKBWMPBKTMU-QHCPKHFHSA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-(2-methoxyethyl)spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C1CN(CCOC)CCC21C(C(=O)N(C[C@H](N)C=1C=CC=CC=1)C(=O)N1CC=3C(=CC=CC=3F)C(F)(F)F)=C1CO2 GLTBKBWMPBKTMU-QHCPKHFHSA-N 0.000 claims 1
- OQHGLVHWYWEAND-QHCPKHFHSA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-(2-methylsulfonylethyl)spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C1CN(CCS(=O)(=O)C)CCC21C(C(=O)N(C[C@H](N)C=1C=CC=CC=1)C(=O)N1CC=3C(=CC=CC=3F)C(F)(F)F)=C1CO2 OQHGLVHWYWEAND-QHCPKHFHSA-N 0.000 claims 1
- MCSBNRCVQWJNKW-NDEPHWFRSA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-(2-phenylethyl)spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CCC1=CC=CC=C1 MCSBNRCVQWJNKW-NDEPHWFRSA-N 0.000 claims 1
- SWTZMQMCTYHWHY-SANMLTNESA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[(2-hydroxyphenyl)methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC=C1O SWTZMQMCTYHWHY-SANMLTNESA-N 0.000 claims 1
- ZNAVZPOLNLHDPQ-NDEPHWFRSA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[(2-methylphenyl)methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound CC1=CC=CC=C1CN1CCC2(C3=C(N(C(=O)N(C[C@H](N)C=4C=CC=CC=4)C3=O)CC=3C(=CC=CC=3F)C(F)(F)F)CO2)CC1 ZNAVZPOLNLHDPQ-NDEPHWFRSA-N 0.000 claims 1
- CXOJTTGFEZQEIH-NDEPHWFRSA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[(3-methylphenyl)methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound CC1=CC=CC(CN2CCC3(CC2)C2=C(N(C(=O)N(C[C@H](N)C=4C=CC=CC=4)C2=O)CC=2C(=CC=CC=2F)C(F)(F)F)CO3)=C1 CXOJTTGFEZQEIH-NDEPHWFRSA-N 0.000 claims 1
- PMRYFOZMMYBETE-NDEPHWFRSA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[(3-methylsulfonylphenyl)methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound CS(=O)(=O)C1=CC=CC(CN2CCC3(CC2)C2=C(N(C(=O)N(C[C@H](N)C=4C=CC=CC=4)C2=O)CC=2C(=CC=CC=2F)C(F)(F)F)CO3)=C1 PMRYFOZMMYBETE-NDEPHWFRSA-N 0.000 claims 1
- YGKLLMCQDBJDQO-MHZLTWQESA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[(4-hydroxyphenyl)methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=C(O)C=C1 YGKLLMCQDBJDQO-MHZLTWQESA-N 0.000 claims 1
- OREWKNMLAMCIIV-NDEPHWFRSA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[(4-methylphenyl)methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C1=CC(C)=CC=C1CN1CCC2(C3=C(N(C(=O)N(C[C@H](N)C=4C=CC=CC=4)C3=O)CC=3C(=CC=CC=3F)C(F)(F)F)CO2)CC1 OREWKNMLAMCIIV-NDEPHWFRSA-N 0.000 claims 1
- WYPJWISCQDRFKJ-SANMLTNESA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[(5-methylfuran-2-yl)methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound O1C(C)=CC=C1CN1CCC2(C3=C(N(C(=O)N(C[C@H](N)C=4C=CC=CC=4)C3=O)CC=3C(=CC=CC=3F)C(F)(F)F)CO2)CC1 WYPJWISCQDRFKJ-SANMLTNESA-N 0.000 claims 1
- UWVCBMPSNFBUFR-VWLOTQADSA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[(6-oxo-1h-pyridin-3-yl)methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC=1C=CC(=O)NC=1 UWVCBMPSNFBUFR-VWLOTQADSA-N 0.000 claims 1
- IJFHAUJNXBIVJJ-JVHFYALYSA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[2-(1-methylpyrrolidin-2-yl)ethyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound CN1CCCC1CCN1CCC2(C3=C(N(C(=O)N(C[C@H](N)C=4C=CC=CC=4)C3=O)CC=3C(=CC=CC=3F)C(F)(F)F)CO2)CC1 IJFHAUJNXBIVJJ-JVHFYALYSA-N 0.000 claims 1
- KJRBCIGGGUDGEI-SANMLTNESA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[[2-(trifluoromethoxy)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC=C1OC(F)(F)F KJRBCIGGGUDGEI-SANMLTNESA-N 0.000 claims 1
- PODOBAKUSZFZAP-MHZLTWQESA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[[2-(trifluoromethyl)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC=C1C(F)(F)F PODOBAKUSZFZAP-MHZLTWQESA-N 0.000 claims 1
- LFGBVAQBOSVEHA-MHZLTWQESA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[[3-(trifluoromethoxy)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC(OC(F)(F)F)=C1 LFGBVAQBOSVEHA-MHZLTWQESA-N 0.000 claims 1
- NJPGPXRBFWIHRI-MHZLTWQESA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[[3-(trifluoromethyl)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC(C(F)(F)F)=C1 NJPGPXRBFWIHRI-MHZLTWQESA-N 0.000 claims 1
- SKSDPNDQCRTXKG-MHZLTWQESA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1'-[[4-(trifluoromethyl)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=C(C(F)(F)F)C=C1 SKSDPNDQCRTXKG-MHZLTWQESA-N 0.000 claims 1
- MOQPSWRADQTBHZ-FQEVSTJZSA-N 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-2,4-dione Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC21CCNCC1 MOQPSWRADQTBHZ-FQEVSTJZSA-N 0.000 claims 1
- HEJVWIQXLYIHKF-NDEPHWFRSA-N 3-[[3-[(2R)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-2,4-dioxospiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-1'-yl]methyl]-N-methylbenzamide Chemical compound N[C@@H](CN1C(N(C2=C(C1=O)C1(OC2)CCN(CC1)CC=1C=C(C(=O)NC)C=CC1)CC1=C(C=CC=C1C(F)(F)F)F)=O)C1=CC=CC=C1 HEJVWIQXLYIHKF-NDEPHWFRSA-N 0.000 claims 1
- KMTWMTWRSGFOSU-NDEPHWFRSA-N 3-[[3-[(2r)-2-amino-2-phenylethyl]-1-[(2,6-difluorophenyl)methyl]-2,4-dioxospiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-1'-yl]methyl]benzonitrile Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC(C#N)=C1 KMTWMTWRSGFOSU-NDEPHWFRSA-N 0.000 claims 1
- ILHYWSYRWQMOCM-MHZLTWQESA-N 3-[[3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-2,4-dioxospiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-1'-yl]methyl]-2-fluorobenzonitrile Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC(C#N)=C1F ILHYWSYRWQMOCM-MHZLTWQESA-N 0.000 claims 1
- XHMIDBZEWBUNKF-NDEPHWFRSA-N 3-[[3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-2,4-dioxospiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-1'-yl]methyl]benzonitrile Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC(C#N)=C1 XHMIDBZEWBUNKF-NDEPHWFRSA-N 0.000 claims 1
- QEKWNCAXKYZTNU-HKBQPEDESA-N 4-[[(1R)-2-[1'-[(3-cyanophenyl)methyl]-1-[(2,6-difluorophenyl)methyl]-2,4-dioxospiro[7H-furo[3,4-d]pyrimidine-5,4'-piperidine]-3-yl]-1-phenylethyl]amino]butanoic acid Chemical compound C(#N)C=1C=C(CN2CCC3(OCC=4N(C(N(C(C43)=O)C[C@@H](C4=CC=CC=C4)NCCCC(=O)O)=O)CC4=C(C=CC=C4F)F)CC2)C=CC1 QEKWNCAXKYZTNU-HKBQPEDESA-N 0.000 claims 1
- ALLOMACTQSFIHI-PMERELPUSA-N 4-[[(1r)-2-[1'-[(3-chlorophenyl)methyl]-1-[(2,6-difluorophenyl)methyl]-2,4-dioxospiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-3-yl]-1-phenylethyl]amino]butanoic acid Chemical compound C([C@H](NCCCC(=O)O)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC(Cl)=C1 ALLOMACTQSFIHI-PMERELPUSA-N 0.000 claims 1
- MUVOHMWIPUOEEE-PMERELPUSA-N 4-[[(1r)-2-[1'-[(3-chlorophenyl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-2,4-dioxospiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-3-yl]-1-phenylethyl]amino]butanoic acid Chemical compound C([C@H](NCCCC(=O)O)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC(Cl)=C1 MUVOHMWIPUOEEE-PMERELPUSA-N 0.000 claims 1
- LOIJGSPNRWAXJH-HKBQPEDESA-N 4-[[(1r)-2-[1'-[(3-cyanophenyl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-2,4-dioxospiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-3-yl]-1-phenylethyl]amino]butanoic acid Chemical compound C([C@H](NCCCC(=O)O)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC(C#N)=C1 LOIJGSPNRWAXJH-HKBQPEDESA-N 0.000 claims 1
- VIVLMLYUHNRGCX-HKBQPEDESA-N 4-[[(1r)-2-[1'-benzyl-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-2,4-dioxospiro[6,7-dihydrocyclopenta[d]pyrimidine-5,4'-piperidine]-3-yl]-1-phenylethyl]amino]butanoic acid Chemical compound C([C@H](NCCCC(=O)O)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1CCC2(CC1)CCN1CC1=CC=CC=C1 VIVLMLYUHNRGCX-HKBQPEDESA-N 0.000 claims 1
- MUVOHMWIPUOEEE-SSEXGKCCSA-N 4-[[(1s)-2-[1'-[(3-chlorophenyl)methyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-2,4-dioxospiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-3-yl]-1-phenylethyl]amino]butanoic acid Chemical compound C([C@@H](NCCCC(=O)O)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=CC(Cl)=C1 MUVOHMWIPUOEEE-SSEXGKCCSA-N 0.000 claims 1
- LLNLZTXEXDPWPT-NDEPHWFRSA-N 4-[[3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-2,4-dioxospiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-1'-yl]methyl]benzonitrile Chemical compound C([C@H](N)C=1C=CC=CC=1)N(C(N1CC=2C(=CC=CC=2F)C(F)(F)F)=O)C(=O)C2=C1COC2(CC1)CCN1CC1=CC=C(C#N)C=C1 LLNLZTXEXDPWPT-NDEPHWFRSA-N 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 201000004384 Alopecia Diseases 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 201000000736 Amenorrhea Diseases 0.000 claims 1
- 206010001928 Amenorrhoea Diseases 0.000 claims 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 201000009273 Endometriosis Diseases 0.000 claims 1
- 102000006771 Gonadotropins Human genes 0.000 claims 1
- 108010086677 Gonadotropins Proteins 0.000 claims 1
- 206010020112 Hirsutism Diseases 0.000 claims 1
- 208000019255 Menstrual disease Diseases 0.000 claims 1
- LKLCGWRIVHNTKU-UHFFFAOYSA-N NC(CN1C(N(C2=C(C1=O)C1(CCN(CC1)CCCS(=O)(=O)NC)OC2)CC1=C(C=CC=C1C(F)(F)F)F)=O)C1=CC=CC=C1 Chemical compound NC(CN1C(N(C2=C(C1=O)C1(CCN(CC1)CCCS(=O)(=O)NC)OC2)CC1=C(C=CC=C1C(F)(F)F)F)=O)C1=CC=CC=C1 LKLCGWRIVHNTKU-UHFFFAOYSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010036049 Polycystic ovaries Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 208000020221 Short stature Diseases 0.000 claims 1
- 208000002495 Uterine Neoplasms Diseases 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 231100000360 alopecia Toxicity 0.000 claims 1
- 231100000540 amenorrhea Toxicity 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 claims 1
- 208000035269 cancer or benign tumor Diseases 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- YSNHVZXTGKRWSW-QFIPXVFZSA-N ethyl 3-[(2r)-2-amino-2-phenylethyl]-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-2,4-dioxospiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-1'-carboxylate Chemical compound C1CN(C(=O)OCC)CCC21C(C(=O)N(C[C@H](N)C=1C=CC=CC=1)C(=O)N1CC=3C(=CC=CC=3F)C(F)(F)F)=C1CO2 YSNHVZXTGKRWSW-QFIPXVFZSA-N 0.000 claims 1
- YBURKGRQNJPCSW-UHFFFAOYSA-N ethyl n-methoxycarbamate Chemical compound CCOC(=O)NOC YBURKGRQNJPCSW-UHFFFAOYSA-N 0.000 claims 1
- 230000035558 fertility Effects 0.000 claims 1
- TVFIYRKPCACCNL-UHFFFAOYSA-N furan-2-carboxamide Chemical compound NC(=O)C1=CC=CO1 TVFIYRKPCACCNL-UHFFFAOYSA-N 0.000 claims 1
- 230000002710 gonadal effect Effects 0.000 claims 1
- 239000002622 gonadotropin Substances 0.000 claims 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 1
- 150000002431 hydrogen Chemical group 0.000 claims 1
- 208000000509 infertility Diseases 0.000 claims 1
- 230000036512 infertility Effects 0.000 claims 1
- 231100000535 infertility Toxicity 0.000 claims 1
- 206010025135 lupus erythematosus Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 201000002511 pituitary cancer Diseases 0.000 claims 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 1
- 208000006155 precocious puberty Diseases 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 201000002859 sleep apnea Diseases 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 1
- 206010046766 uterine cancer Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2012-0020479 | 2012-02-28 | ||
| KR20120020479 | 2012-02-28 | ||
| PCT/KR2013/001660 WO2013129879A1 (en) | 2012-02-28 | 2013-02-28 | Gonadotropin releasing hormone receptor antagonists, method for the preparation thereof and pharmaceutical composition comprising the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015510868A JP2015510868A (ja) | 2015-04-13 |
| JP2015510868A5 true JP2015510868A5 (enExample) | 2017-05-18 |
| JP6209171B2 JP6209171B2 (ja) | 2017-10-04 |
Family
ID=49082998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014559833A Active JP6209171B2 (ja) | 2012-02-28 | 2013-02-28 | ゴナドトロピン放出ホルモン受容体アンタゴニスト、その製造方法および該アンタゴニストを含む医薬組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9481684B2 (enExample) |
| EP (1) | EP2820021B1 (enExample) |
| JP (1) | JP6209171B2 (enExample) |
| KR (1) | KR101495260B1 (enExample) |
| CN (2) | CN105732649B (enExample) |
| AU (1) | AU2013226661B2 (enExample) |
| BR (1) | BR112014021331B1 (enExample) |
| CA (1) | CA2865547C (enExample) |
| ES (1) | ES2613856T3 (enExample) |
| MX (1) | MX357841B (enExample) |
| WO (1) | WO2013129879A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104884457B (zh) * | 2013-10-30 | 2016-12-07 | 上海恒瑞医药有限公司 | 吡唑并嘧啶酮类或吡咯并三嗪酮类衍生物、其制备方法及其在医药上的应用 |
| WO2019020102A1 (zh) * | 2017-07-28 | 2019-01-31 | 江苏恒瑞医药股份有限公司 | 一种嘧啶酮并杂芳基类衍生物的制备方法及其中间体 |
| KR101973074B1 (ko) | 2018-11-30 | 2019-04-26 | 주식회사 티움바이오 | 퓨로피리미딘 화합물의 염 및 결정형, 및 이를 포함하는 약학적 조성물 |
| CN109651265A (zh) * | 2019-02-16 | 2019-04-19 | 安徽诺全药业有限公司 | 一种Elagolix的制备方法 |
| JP7066913B2 (ja) | 2019-03-26 | 2022-05-13 | ノベルファーマ株式会社 | 持続型脂肪酸結合ＧｎＲＨ誘導体及びこれを含む薬剤学的組成物 |
| KR20210155350A (ko) | 2020-06-15 | 2021-12-22 | 한상왕 | 녹차 추출물 및 비타민 d3를 유효성분으로 포함하는 자궁근종 개선용 조성물 |
| CN115124545B (zh) * | 2022-08-31 | 2023-01-03 | 南京远淑医药科技有限公司 | 一种促性腺激素释放激素受体拮抗剂中间体的合成方法 |
| KR102738115B1 (ko) | 2024-03-25 | 2024-12-05 | 한상왕 | 자궁근종 예방, 개선 또는 치료용 약학 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2163325A1 (en) * | 1994-11-21 | 1996-05-22 | Kaneyoshi Kato | Amine compounds, their production and use |
| US6156772A (en) * | 1997-06-05 | 2000-12-05 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| TWI225863B (en) * | 1999-03-24 | 2005-01-01 | Takeda Chemical Industries Ltd | Thienopyrimidine compounds, their production and use |
| CA2386942A1 (en) * | 1999-10-15 | 2001-04-26 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| US6740656B2 (en) * | 2001-08-02 | 2004-05-25 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| FR2833948B1 (fr) * | 2001-12-21 | 2004-02-06 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et leur utilisation en tant que medicament |
| CA2489252A1 (en) * | 2002-06-13 | 2003-12-24 | Pfizer Inc. | Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| US20090048273A1 (en) * | 2005-07-22 | 2009-02-19 | Takeda Pharmaceutical Company Limited | Premature ovulation preventive agent |
| US9034850B2 (en) * | 2009-11-20 | 2015-05-19 | Sk Chemicals Co., Ltd. | Gonadotropin releasing hormone receptor antagonist, preparation method thereof and pharmaceutical composition comprising the same |
-
2013
- 2013-02-28 CA CA2865547A patent/CA2865547C/en active Active
- 2013-02-28 KR KR20130022105A patent/KR101495260B1/ko active Active
- 2013-02-28 CN CN201610104516.XA patent/CN105732649B/zh active Active
- 2013-02-28 AU AU2013226661A patent/AU2013226661B2/en active Active
- 2013-02-28 CN CN201380011513.6A patent/CN104136441B/zh active Active
- 2013-02-28 US US14/381,371 patent/US9481684B2/en active Active
- 2013-02-28 BR BR112014021331-3A patent/BR112014021331B1/pt active IP Right Grant
- 2013-02-28 ES ES13754960T patent/ES2613856T3/es active Active
- 2013-02-28 MX MX2014010345A patent/MX357841B/es active IP Right Grant
- 2013-02-28 WO PCT/KR2013/001660 patent/WO2013129879A1/en not_active Ceased
- 2013-02-28 JP JP2014559833A patent/JP6209171B2/ja active Active
- 2013-02-28 EP EP13754960.6A patent/EP2820021B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015510868A5 (enExample) | ||
| CN115605476B (zh) | 取代的三环化合物 | |
| JP4958772B2 (ja) | 脈管形成に関連する高増殖性疾患および疾患を処置するために有用なピロロトリアジン誘導体 | |
| CN107295799B (zh) | Parg抑制化合物 | |
| KR101817221B1 (ko) | 치환된 4-(셀레노펜-2(또는 3)-일아미노)피리미딘 화합물 및 이의 사용방법 | |
| JP2009524670A5 (enExample) | ||
| CN102007125B (zh) | 稠合杂环衍生物及使用方法 | |
| JP2016523922A5 (enExample) | ||
| RU2018123779A (ru) | Новые соединения | |
| JP2020519589A5 (enExample) | ||
| JP2009528389A5 (enExample) | ||
| RU2016137169A (ru) | Гетероциклические соединения, способ их получения и их применение | |
| JPWO2006051704A1 (ja) | イミン化合物 | |
| JP2007509141A5 (enExample) | ||
| JP2017530960A5 (enExample) | ||
| JP2013515729A5 (enExample) | ||
| RU2008107264A (ru) | Производные пиразина, полезные в качестве антагонистов аденозинового рецептора | |
| AU2005238386A1 (en) | Heterocyclic amide compound and use thereof as an MMP-13 inhibitor | |
| JP2017537137A (ja) | Ｐａｒｇの阻害剤としての２，４−ジオキソ−キナゾリン−６−スルホンアミド誘導体 | |
| RU2642779C2 (ru) | Ингибиторы сомт | |
| CN109153649A (zh) | 烟碱乙酰胆碱受体的变构调节剂 | |
| WO2011055115A1 (en) | Akt / pkb inhibitors | |
| JP2013520407A5 (enExample) | ||
| JP2011529102A (ja) | Ｓｍｏアンタゴニストとしての１，２，４−オキサジアゾール置換ピペリジン及びピペラジン誘導体 | |
| JP2013514973A (ja) | チロシンキナーゼ阻害剤 |